Herold Tina R, Liegl Raffael, Koenig Susanna, Almarzooqi Ahmed, Priglinger Siegfried G, Wolf Armin
Department of Ophthalmology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.
Department of Ophthalmology, University Hospital, Technical University of Munich, Munich, Germany.
Ophthalmol Ther. 2020 Mar;9(1):175-179. doi: 10.1007/s40123-020-00232-2. Epub 2020 Feb 13.
While proven to be an effective treatment for cystoid macular edema (CME) and diabetic macular edema, intravitreal steroid implants (IVSI) may cause undesirable side effects, including steroid-related glaucoma or migration into the anterior chamber in the case of iris-lens diaphragm disruption. Here we present a new surgical technique that allows for the easy implantation and subsequent fixation of the fluocinolone acetonide intravitreal implant without the risk of migration as a feasible and possibly reversible approach in the treatment of persistent CME in severely damaged eyes.
In this single-center, prospective off-label, proof of principle, scleral fixation of the fluocinolone implant was performed in two eyes with disrupted anterior-posterior segment border and persistent CME. Both eyes were then followed monthly in accordance to a detailed protocol.
The procedure was overall well tolerated without severe side effects. There was no migration of the implant in the anterior chamber in either eye.
Scleral fixation of the fluocinolone implant proved to be a safe and feasible approach in eyes with persistent CME and disrupted anterior-posterior segment border. This new technique also allows for the possible removal of the implant and may therefore be suitable even for eyes at higher risk for side effects, such as glaucoma.
虽然玻璃体内类固醇植入物(IVSI)已被证明是治疗黄斑囊样水肿(CME)和糖尿病性黄斑水肿的有效方法,但它可能会引起不良副作用,包括类固醇相关的青光眼,或者在虹膜 - 晶状体膈破裂的情况下迁移至前房。在此,我们介绍一种新的手术技术,该技术可使曲安奈德玻璃体内植入物易于植入并随后固定,且不存在迁移风险,是治疗严重受损眼睛中持续性CME的一种可行且可能可逆的方法。
在这个单中心、前瞻性、非标签、原理验证研究中,对两只前后节边界中断且患有持续性CME的眼睛进行了曲安奈德植入物的巩膜固定术。然后按照详细方案对两只眼睛每月进行随访。
该手术总体耐受性良好,无严重副作用。两只眼睛的植入物均未迁移至前房。
对于患有持续性CME且前后节边界中断的眼睛,曲安奈德植入物的巩膜固定术被证明是一种安全可行的方法。这种新技术还允许可能取出植入物,因此甚至可能适用于发生副作用风险较高的眼睛,如青光眼患者的眼睛。